| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A biopsychosocial model to understand racial disparities in the era of cancer immunotherapy
|
Yao, Song
|
|
|
|
1 |
p. 6-8
|
artikel
|
| 2 |
Advisory Board and Contents
|
|
|
|
|
1 |
p. i
|
artikel
|
| 3 |
Advisory Board and Contents
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 4 |
Advisory Board and Contents
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 5 |
Advisory Board and Contents
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 6 |
Aneuploidy in Cancer: Lessons from Acute Lymphoblastic Leukemia
|
Molina, Oscar
|
|
|
|
1 |
p. 37-47
|
artikel
|
| 7 |
Angiogenesis and Metabolism: Entwined for Therapy Resistance
|
Jiménez-Valerio, Gabriela
|
|
2017
|
|
1 |
p. 10-18
|
artikel
|
| 8 |
Anton Berns: Modeling Cancer
|
|
|
2015
|
|
1 |
p. 13-14
|
artikel
|
| 9 |
A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality
|
Parameswaran, Sreejit
|
|
2019
|
|
1 |
p. 11-29
|
artikel
|
| 10 |
Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms
|
Li, Gang
|
|
|
|
1 |
p. 65-80
|
artikel
|
| 11 |
Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors
|
Liu, Weici
|
|
|
|
1 |
p. 5-7
|
artikel
|
| 12 |
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
|
Lipinski, Kamil A.
|
|
2016
|
|
1 |
p. 49-63
|
artikel
|
| 13 |
Cancer fitness genes: emerging therapeutic targets for metastasis
|
Shen, Minhong
|
|
|
|
1 |
p. 69-82
|
artikel
|
| 14 |
Cancer Genomics in Clinical Context
|
Chin, Lynda
|
|
2015
|
|
1 |
p. 36-43
|
artikel
|
| 15 |
Capicua in Human Cancer
|
Kim, Ji Won
|
|
|
|
1 |
p. 77-86
|
artikel
|
| 16 |
Cellular Mechanisms Underlying Intertumoral Heterogeneity
|
Sutherland, Kate D.
|
|
2015
|
|
1 |
p. 15-23
|
artikel
|
| 17 |
Challenges in glioblastoma research: focus on the tumor microenvironment
|
Bikfalvi, Andreas
|
|
|
|
1 |
p. 9-27
|
artikel
|
| 18 |
Chemical-genetics refines transcription factor regulatory circuits
|
Layden, Hillary M.
|
|
|
|
1 |
p. 65-75
|
artikel
|
| 19 |
Chromosomal instability and aneuploidy as causes of cancer drug resistance
|
Lukow, Devon A.
|
|
|
|
1 |
p. 43-53
|
artikel
|
| 20 |
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response
|
Nagelli, Srikar
|
|
|
|
1 |
p. 52-64
|
artikel
|
| 21 |
Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
|
Garrido, Amanda
|
|
|
|
1 |
p. 29-36
|
artikel
|
| 22 |
Clinical Trials Transparency: Where Are We Today?
|
Dal-Ré, Rafael
|
|
2018
|
|
1 |
p. 1-3
|
artikel
|
| 23 |
Convergent insights into intratumor heterogeneity
|
Manini, Claudia
|
|
|
|
1 |
p. 12-14
|
artikel
|
| 24 |
Craig Thompson: Fueling Cancer
|
|
|
2015
|
|
1 |
p. 12-13
|
artikel
|
| 25 |
DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells
|
Putzbach, William
|
|
2018
|
|
1 |
p. 10-19
|
artikel
|
| 26 |
Dissemination from a Solid Tumor: Examining the Multiple Parallel Pathways
|
Katt, Moriah E.
|
|
2018
|
|
1 |
p. 20-37
|
artikel
|
| 27 |
DNA-Targeted Precision Medicine; Have We Been Caught Sleeping?
|
Reinhold, William C.
|
|
2017
|
|
1 |
p. 2-6
|
artikel
|
| 28 |
Douglas Lowy: Precision Medicine Gets Presidential Treatment
|
|
|
2015
|
|
1 |
p. 3-4
|
artikel
|
| 29 |
Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer
|
Bursać, Slađana
|
|
|
|
1 |
p. 57-76
|
artikel
|
| 30 |
Editorial Board and Contents
|
|
|
2018
|
|
1 |
p. i
|
artikel
|
| 31 |
Editorial Board and Contents
|
|
|
2016
|
|
1 |
p. i
|
artikel
|
| 32 |
Editorial Board and Contents
|
|
|
2017
|
|
1 |
p. i
|
artikel
|
| 33 |
Editorial Board and Contents
|
|
|
2019
|
|
1 |
p. i
|
artikel
|
| 34 |
Editors, Contents, Cover details
|
|
|
2015
|
|
1 |
p. i-ii
|
artikel
|
| 35 |
Education and Outreach in Physical Sciences in Oncology
|
Walker, Sierra A.
|
|
|
|
1 |
p. 3-9
|
artikel
|
| 36 |
Endogenous retroelements as alarms for disruptions to cellular homeostasis
|
Lindholm, Håvard T.
|
|
|
|
1 |
p. 55-68
|
artikel
|
| 37 |
En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition
|
Aceto, Nicola
|
|
2015
|
|
1 |
p. 44-52
|
artikel
|
| 38 |
ERAP1 as an emerging therapeutic target for medulloblastoma
|
Bufalieri, Francesca
|
|
|
|
1 |
p. 4-8
|
artikel
|
| 39 |
Exploiting cancer’s drinking problem: regulation and therapeutic potential of macropinocytosis
|
Puccini, Joseph
|
|
|
|
1 |
p. 54-64
|
artikel
|
| 40 |
From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm
|
Adashek, Jacob J.
|
|
|
|
1 |
p. 15-28
|
artikel
|
| 41 |
Gastrointestinal Stromal Tumors: The GIST of Precision Medicine
|
Mei, Lin
|
|
2018
|
|
1 |
p. 74-91
|
artikel
|
| 42 |
Genomic Landscape of Pheochromocytoma and Paraganglioma
|
Jochmanova, Ivana
|
|
2018
|
|
1 |
p. 6-9
|
artikel
|
| 43 |
Glioblastoma Therapy in the Age of Molecular Medicine
|
Geraldo, Luiz Henrique Medeiros
|
|
2019
|
|
1 |
p. 46-65
|
artikel
|
| 44 |
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
|
Wang, Zhanyu
|
|
2019
|
|
1 |
p. 30-45
|
artikel
|
| 45 |
Glucose-Regulated TET2 Activity Links Cancer to Diabetes
|
Singh, Hari R.
|
|
2019
|
|
1 |
p. 5-7
|
artikel
|
| 46 |
Gut microbiota – a double-edged sword in cancer immunotherapy
|
Andrews, Miles C.
|
|
|
|
1 |
p. 3-5
|
artikel
|
| 47 |
How cancer cells make and respond to interferon-I
|
Cheon, HyeonJoo
|
|
|
|
1 |
p. 83-92
|
artikel
|
| 48 |
Immune Response to Cancer Therapy: Mounting an Effective Antitumor Response and Mechanisms of Resistance
|
Medler, Terry R.
|
|
2015
|
|
1 |
p. 66-75
|
artikel
|
| 49 |
Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’
|
Prendergast, George C.
|
|
2018
|
|
1 |
p. 38-58
|
artikel
|
| 50 |
Intercellular Conduits in Tumors: The New Social Network
|
Lou, Emil
|
|
2016
|
|
1 |
p. 3-5
|
artikel
|
| 51 |
Karen Vousden: Complexities of Tumor Suppression
|
|
|
2015
|
|
1 |
p. 10-11
|
artikel
|
| 52 |
Mice Are Not Humans: The Case of p53
|
Fischer, Martin
|
|
|
|
1 |
p. 12-14
|
artikel
|
| 53 |
Microfluidics: A New Tool for Modeling Cancer–Immune Interactions
|
Boussommier-Calleja, Alexandra
|
|
2016
|
|
1 |
p. 6-19
|
artikel
|
| 54 |
Mina J. Bissell: Context Matters
|
|
|
2015
|
|
1 |
p. 6-8
|
artikel
|
| 55 |
Multimodal immunostimulation to control BRCA1-defective ovarian carcinoma
|
Klapp, Vanessa
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 56 |
myCAFs are better than yours: targeting myofibroblasts potentiates immunotherapy
|
Monteran, Lea
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 57 |
MYC: A Stratification Marker for Pancreatic Cancer Therapy
|
Wirth, Matthias
|
|
2016
|
|
1 |
p. 1-3
|
artikel
|
| 58 |
Nanoluminal Signaling Shapes Collective Metastasis
|
Gensbittel, Valentin
|
|
|
|
1 |
p. 9-11
|
artikel
|
| 59 |
Necroptosis and tumor progression
|
Yan, Jiong
|
|
|
|
1 |
p. 21-27
|
artikel
|
| 60 |
NLRC5/CITA: A Key Player in Cancer Immune Surveillance
|
Yoshihama, Sayuri
|
|
2017
|
|
1 |
p. 28-38
|
artikel
|
| 61 |
Non-genetic mechanisms of drug resistance in acute leukemias
|
Calderon, Alexander
|
|
|
|
1 |
p. 38-51
|
artikel
|
| 62 |
Ontogeny of Tumor-Associated Macrophages and Its Implication in Cancer Regulation
|
Franklin, Ruth A.
|
|
2016
|
|
1 |
p. 20-34
|
artikel
|
| 63 |
Peter Jones: Leaving a Mark on the Cancer Genome
|
|
|
2015
|
|
1 |
p. 8-9
|
artikel
|
| 64 |
PRC1: Linking Cytokinesis, Chromosomal Instability, and Cancer Evolution
|
Li, Jing
|
|
2018
|
|
1 |
p. 59-73
|
artikel
|
| 65 |
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
|
Sattler, Martin
|
|
|
|
1 |
p. 42-54
|
artikel
|
| 66 |
Protein N-Homocysteinylation and Colorectal Cancer
|
Jakubowski, Hieronim
|
|
2019
|
|
1 |
p. 7-10
|
artikel
|
| 67 |
Radiotherapy and immunotherapy: open questions and future strategies
|
Pointer, Kelli B.
|
|
|
|
1 |
p. 9-20
|
artikel
|
| 68 |
Rapid Research Autopsy: Piecing the Puzzle of Tumor Heterogeneity
|
Krook, Melanie A.
|
|
2019
|
|
1 |
p. 1-5
|
artikel
|
| 69 |
Revisiting the HIF switch in the tumor and its immune microenvironment
|
Cowman, Sophie J.
|
|
|
|
1 |
p. 28-42
|
artikel
|
| 70 |
Robert Weinberg: Beyond Hallmarks
|
|
|
2015
|
|
1 |
p. 4-5
|
artikel
|
| 71 |
Science that Inspires
|
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 72 |
Secondary Necrosis: Accidental No More
|
Galluzzi, Lorenzo
|
|
2017
|
|
1 |
p. 1-2
|
artikel
|
| 73 |
Senescent stromal cells: roles in the tumor microenvironment
|
Gabai, Yael
|
|
|
|
1 |
p. 28-41
|
artikel
|
| 74 |
Serrated colorectal cancer: preclinical models and molecular pathways
|
Aiderus, Aziz
|
|
|
|
1 |
p. 76-91
|
artikel
|
| 75 |
Signatures of Breast Cancer Metastasis: aMENAble to Interpretation?
|
Oudin, Madeleine J.
|
|
2017
|
|
1 |
p. 7-9
|
artikel
|
| 76 |
‘Slicing’ glioblastoma drivers with the Swiss cheese model
|
Teran Pumar, Oriana Y.
|
|
|
|
1 |
p. 15-27
|
artikel
|
| 77 |
Subscription and copyright page
|
|
|
|
|
1 |
p. e1
|
artikel
|
| 78 |
Subscription & copyright page
|
|
|
|
|
1 |
p. e1
|
artikel
|
| 79 |
Subscription & copyright page
|
|
|
|
|
1 |
p. e1
|
artikel
|
| 80 |
Subscription & copyright page
|
|
|
|
|
1 |
p. e1
|
artikel
|
| 81 |
Surviving at a Distance: Organ-Specific Metastasis
|
Obenauf, Anna C.
|
|
2015
|
|
1 |
p. 76-91
|
artikel
|
| 82 |
Suzanne Topalian: Unleashing the Immune System to Fight Cancer
|
|
|
2015
|
|
1 |
p. 9-10
|
artikel
|
| 83 |
Targeted Therapy and Immunosuppression in the Tumor Microenvironment
|
Allegrezza, Michael J.
|
|
2017
|
|
1 |
p. 19-27
|
artikel
|
| 84 |
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer
|
Karamouzis, Michalis V.
|
|
2016
|
|
1 |
p. 35-48
|
artikel
|
| 85 |
Targeting immunogenic cell death for glioma immunotherapy
|
Mishchenko, Tatiana A.
|
|
|
|
1 |
p. 8-11
|
artikel
|
| 86 |
Targeting TGF-β Signaling in Cancer
|
Colak, Selcuk
|
|
2017
|
|
1 |
p. 56-71
|
artikel
|
| 87 |
Targeting Transcription Factors in Cancer
|
Bhagwat, Anand S.
|
|
2015
|
|
1 |
p. 53-65
|
artikel
|
| 88 |
TGF-β Family Signaling Pathways in Cellular Dormancy
|
Prunier, Chloé
|
|
2019
|
|
1 |
p. 66-78
|
artikel
|
| 89 |
The Anticancer Potential of T Cell Receptor-Engineered T Cells
|
Ecsedi, Matyas
|
|
|
|
1 |
p. 48-56
|
artikel
|
| 90 |
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real?
|
Thomas, Ryan M.
|
|
2015
|
|
1 |
p. 24-35
|
artikel
|
| 91 |
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies
|
Knudsen, Erik S.
|
|
2017
|
|
1 |
p. 39-55
|
artikel
|
| 92 |
The tumor-draining lymph node as a reservoir for systemic immune surveillance
|
Delclaux, Ines
|
|
|
|
1 |
p. 28-37
|
artikel
|
| 93 |
Transforming Biomarker Development with Exceptional Responders
|
Jonsson, Philip
|
|
2018
|
|
1 |
p. 3-6
|
artikel
|
| 94 |
Updating cancer research with patient-focused networks
|
Valiente, Manuel
|
|
|
|
1 |
p. 1-4
|
artikel
|
| 95 |
Welcome to Trends in Cancer
|
|
|
2015
|
|
1 |
p. 1-2
|
artikel
|
Tijdschrift beschrijving